Earnings: Chugai Pharmaceutical and Nomura Research Institute win IR Excellence Grand Awards; growth strategy communications recognised

The Japan Investor Relations Association announced the winners of the 2026 IR Excellence Grand Awards, with Chugai Pharmaceutical and Nomura Research Institute selected for the grand awards. The quality of growth-strategy communications and information disclosure were the key evaluation criteria.

Read in fullFrom the source, not the headline

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

The Japan Investor Relations Association announced the winners of the 2026 IR Excellence Grand Awards on the 12th. Of the 359 companies that applied, 13 were selected as award winners. Chugai Pharmaceutical and Nomura Research Institute (NRI) were selected for the 2 grand awards.

Chugai Pharmaceutical was recognised for clearly presenting its long-term growth strategy and providing more opportunities to explain its research and development activities. NRI's evaluation reflected its management strategy of using AI to identify changes in the business environment at an early stage and connect them to business opportunities.

At a glance

Grand PrizeChugai Pharmaceutical and Nomura Research Institute won awards

Number of entries359 listed companies applied

Number selected13 companies were selected

Overall ratingClarity and disclosure of growth strategies

Chair of the judging panelKitagawa Tetsuo (北川哲雄) pointed this out

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

google.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.